Minneapolis, MNNCT05682144Now EnrollingIRB Ready

Mucopolysaccharidosis IH/S Clinical Trial in Minneapolis, MN

Access cutting-edge mucopolysaccharidosis ih/s treatment through this phase 1 clinical trial at a research site in Minneapolis. Study-provided care at no cost to qualified participants.

Sponsored by Immusoft of CA, Inc.

Quick Self-Assessment

See if you qualify for this Minneapolis location

Preparing your pre-screening questions…

Expert Care in Minneapolis

Access mucopolysaccharidosis ih/s specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related mucopolysaccharidosis ih/s treatment provided free

Apply for This Minneapolis Location

Check if you qualify for this mucopolysaccharidosis ih/s clinical trial in Minneapolis, MN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Minneapolis

    Convenient for MN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Minneapolis site if eligible
  4. 4Begin participation

About This Mucopolysaccharidosis IH/S Study in Minneapolis

A first-in-human study using ISP-001 in patients with Mucopolysaccharidosis Type I Hurler-Scheie and Scheie.

Sponsor: Immusoft of CA, Inc.

Who Can Participate

Inclusion Criteria

Diagnosis of Mucopolysaccharidosis type I Hurler-Scheie or Scheie syndrome.
Age ≥ 10 years at time of study registration.
Creatinine clearance, calculated or measured directly, that is \>60ml/min/1.73m2.
Ejection fraction ≥ 40% by echocardiogram.
Must commit to traveling to the study site for the necessary follow-up evaluations.
Must agree to stay \<45-minute drive from the study site for a minimum of 5 days after cell infusion.

Exclusion Criteria

Known familial inherited cancer syndrome. Suspected cases will be investigated, per the physicians discretion, using relevant genetic tests to determine presence of germline mutations.
History of B cell related cancer, EBV lymphoproliferative disease or autoimmune disorders.
Evidence of active graft-vs-host disease.
Underwent a previous hematopoietic stem cell transplant (HSCT).
Requirement for systemic immune suppression.
Requirement for continuous supplemental oxygen.
Any medical condition likely to interfere with assessment of safety or efficacy of the study treatment.
In the investigator's judgement, the subject is unlikely to complete all protocol-required study visits or procedures, including follow up visits, or comply with the study requirements for participation. Other protocol defined inclusion/exclusion criteria may apply.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Minneapolis?

Yes, this clinical trial (NCT05682144) has an active research site in Minneapolis, MN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Mucopolysaccharidosis IH/S Treatment Options in Minneapolis, MN

If you're searching for mucopolysaccharidosis ih/s treatment options in Minneapolis, MN, this clinical trial (NCT05682144) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Minneapolis research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced mucopolysaccharidosis ih/s specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all mucopolysaccharidosis ih/s clinical trials near you to find additional studies recruiting in your area.

More Ulcerative Colitis Trials in Minneapolis, MN

See all ulcerative colitis clinical trials recruiting in Minneapolis — not just this study.

Browse Ulcerative Colitis Trials in Minneapolis →

Browse More Trials by Condition

Ulcerative Colitis TrialsAll Conditions →

Ready to Join in Minneapolis?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Minneapolis, MN